Biogenesis Bago


Global biotechnology company focused on development, production and commercialization of animal-health products and services. Operates in ~60 countries with a workforce of ~1,300 employees. Core activities include vaccine and biologics development and manufacturing, production and supply of veterinary pharmaceuticals (including reproductive and hormone therapies), and deployment of prevention programs aligned with One Health principles. The company reports large-scale supply to public-health programs (e.g., rabies vaccine doses supplied to multiple countries) and maintains compliance and integrity programs and data-protection practices under Argentine law.

Industries

biotechnology
pharmaceutical
veterinary

Nr. of Employees

large (251-1000)

Biogenesis Bago

Av. Córdoba 950, Piso 12°, Of. “D”, Ciudad Autónoma de Buenos Aires, Argentina


Products

GESTAVET (serum gonadotrophin + chorionic gonadotrophin for injection)

Freeze-dried injection combining PMSG and hCG for induction and synchronization of estrus in sows; reconstituted prior to intramuscular administration.

D-Cloprostenol sodium injection (prostaglandin)

Injectable prostaglandin analogue for luteolysis and induction of estrus or parturition in livestock; provided as a clear liquid formulation.

Oxytocin injection

Injectable oxytocin for induction of uterine contractions, obstetric use and milk letdown support.

Progesterone injection

Injectable progesterone formulation used to modulate estrous cycles and reduce risk of early pregnancy loss in certain indications.


Services

End-to-end services from R&D to large-scale manufacturing and commercial distribution of vaccines, biologics and veterinary pharmaceuticals.

On-field technical assistance, training and guidance for correct application of products and optimization of herd health.

Company-level integrity program delivery including Code of Ethics, training, policies, Ethics Committee oversight and a confidential reporting channel.

Expertise Areas

  • Veterinary vaccine development
  • Biologics and vaccine manufacturing
  • Veterinary pharmaceutical formulation
  • Preventive veterinary medicine and vaccination programs
  • Show More (4)

Key Technologies

  • Vaccine manufacturing
  • Lyophilization (freeze-drying)
  • Injectable formulation
  • Oral pharmaceutical solutions
  • Show More (4)

News & Updates

Reported supply of more than 140 million doses of canine rabies vaccine to 15 countries as supplier to regional public-health mechanisms.


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.